GSK Inks $2 Billion For Cough Medicine Biotech To Bolster Drug Pipeline

GSK said Bellus ’ experimental cough medicine could help treat millions of people with untreatable chronic coughs and had “significant sales potential” if approved.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news topline Source Type: news